| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Metzinger Joseph Anthony | VP, Chief Accounting Officer | C/O DYNAVAX TECHNOLOGIES, 2100 POWELL STREET, SUITE 720, EMERYVILLE | /s/ Joseph A. Metzinger | 2025-05-13 | 0002067729 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | DVAX | Option (Right to Buy) | Award | +31.5K | 31.5K | May 12, 2025 | Common Stock | 31.5K | $9.85 | Direct | F1 | |||
| transaction | DVAX | Restricted Stock Unit | Award | +38.2K | 38.2K | May 12, 2025 | Common Stock | 38.2K | Direct | F2 |
| Id | Content |
|---|---|
| F1 | This option grant will vest over three (3) years with one third (1/3) of the shares subject to the option vesting twelve months after the grant date of May 12, 2025, and one thirty-sixth (1/36) of the shares subject to the option vesting each month thereafter. |
| F2 | Each RSU represents a contingent right to receive one share of common stock. The RSUs vest over three years with 1/3 vesting on each annual anniversary of May 12, 2025. |